Dependence of interleukin-1-induced arthritis on granulocyte-macrophage colony-stimulating factor.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Arthritis & Rheumatism

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/1529-0131(200101)44:1<111::AID-ANR15>3.0.CO;2-1PMID 11212148
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Exacerbation of acute inflammatory arthritis by the colony‐stimulating factors CSF‐1 and granulocyte macrophage (GM)‐CSF: evidence of macrophage infiltration and local proliferation

  2000cited by this paper
• Cytokine-Activated Endothelial Cells Delay Neutrophil Apoptosis in Vitro and in Vivo

  1999cited by this paper
• Pathogenesis of joint damage in rheumatoid arthritis: evidence of a dominant role for interleukin-I.

  1999cited by this paper
• Immunological evaluation of cytokine and anticytokine immunotherapy in vivo: what have we learnt?

  1999cited by this paper
• Mechanism of joint destruction in rheumatoid arthritis.

  1998cited by this paper
• Involvement of macrophage migration inhibitory factor in the evolution of rat adjuvant arthritis.

  1998cited by this paper
• Protection from collagen-induced arthritis in granulocyte-macrophage colony-stimulating factor-deficient mice.

  1998cited by this paper
• Granulocyte-macrophage colony stimulating factor exacerbates collagen induced arthritis in mice

  1997cited by this paper
• T cell functions in granulocyte/macrophage colony-stimulating factor deficient mice.

  1997cited by this paper
• Phagocytic lining cells determine local expression of inflammation in type II collagen-induced arthritis.

  1996cited by this paper
• Role of cytokines in rheumatoid arthritis.

  1996cited by this paper
• Cytokine networks in rheumatoid arthritis: implications for therapy.

  1995cited by this paper
• Decreased atherosclerosis in mice deficient in both macrophage colony-stimulating factor (op) and apolipoprotein E.

  1995cited by this paper
• Agents that elevate cAMP inhibit human neutrophil apoptosis.

  1995cited by this paper
• Osteopetrotic (op/op) mice deficient in macrophages have the ability to mount a normal T-cell-dependent immune response.

  1995cited by this paper
• Functional hierarchy of c-kit and c-fms in intramarrow production of CFU-M.

  1995cited by this paper
• Role of colony stimulating factor-1 in the establishment and regulation of tissue macrophages during postnatal development of the mouse.

  1994cited by this paper
• Granulocyte/macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology.

  1994cited by this paper
• Production of macrophage colony-stimulating factor (M-CSF) by human articular cartilage and chondrocytes. Modulation by interleukin-1 and tumor necrosis factor alpha.

  1993cited by this paper
• Colony stimulating factors, cytokines and monocyte-macrophages--some controversies.

  1993cited by this paper
• Rheumatoid arthritis: opposing actions of haemopoietic growth factors and slow-acting anti-rheumatic drugs

  1993cited by this paper
• Regulation of macrophage colony-stimulating factor (M-CSF) production in cultured human synovial fibroblasts.

  1993cited by this paper
• In vivo role of phagocytic synovial lining cells in onset of experimental arthritis.

  1993cited by this paper
• Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor

  1992cited by this paper
• Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products.

  1992cited by this paper
• Prolongation of survival of human polymorphonuclear neutrophils by granulocyte-macrophage colony-stimulating factor is caused by inhibition of programmed cell death.

  1992cited by this paper
• The Florey Lecture, 1991. The colony-stimulating factors: discovery to clinical use.

  1991cited by this paper
• Flare-up of rheumatoid arthritis during GM-CSF treatment after chemotherapy.

  1991cited by this paper
• The role of macrophages in experimental arthritis induced by Streptococcus agalactiae sonicate: actions of macrophage colony-stimulating factor (CSF-1) and other macrophage-modulating agents.

  1991cited by this paper
• Human articular cartilage and chondrocytes produce hemopoietic colony-stimulating factors in culture in response to IL-1.

  1991cited by this paper
• Cytokine regulation of colony-stimulating factor production in cultured human synovial fibroblasts: I. Induction of GM-CSF and G-CSF production by interleukin-1 and tumor necrosis factor.

  1990cited by this paper
• Induction of an acute erosive monarticular arthritis in mice by interleukin-1 and methylated bovine serum albumin.

  1990cited by this paper
• Cytokines in chronic inflammatory arthritis. II. Granulocyte-macrophage colony-stimulating factor in rheumatoid synovial effusions.

  1989cited by this paper
• Cytokines in chronic inflammatory arthritis. IV. Granulocyte/macrophage colony-stimulating factor-mediated induction of class II MHC antigen on human monocytes: a possible role in rheumatoid arthritis

  1989cited by this paper
• The BCL1 B lymphoma responds to IL-4, IL-5, and GM-CSF.

  1989cited by this paper
• Cytokines in chronic inflammatory arthritis. I. Failure to detect T cell lymphokines (interleukin 2 and interleukin 3) and presence of macrophage colony-stimulating factor (CSF-1) and a novel mast cell growth factor in rheumatoid synovitis

  1988cited by this paper
• Stimulation of macrophage plasminogen activator activity by colony‐stimulating factors

  1980cited by this paper

• Serum amyloid A expression in liver promotes synovial macrophage activation and chronic arthritis via NFAT5

  2024cites this paper
• The acute phase reactant orosomucoid-2 directly promotes rheumatoid inflammation

  2024cites this paper
• Sterile triggers drive joint inflammation in TNF‐ and IL‐1β‐dependent mouse arthritis models

  2023cites this paper
• Sterile triggers drive joint inflammation in TNF and IL-1β dependent mouse arthritis models

  2023cites this paper
• CCL17 in Inflammation and Pain

  2020cites this paper
• TYK2 inhibition reduces type 3 immunity and modifies disease progression in murine spondyloarthritis

  2020cites this paper
• IL-23 in arthritic and inflammatory pain development in mice

  2020cites this paper
• Induction of pro-inflammatory cytokines by 29-kDa FN-f via cGAS/STING pathway

  2019cites this paper
• GM-CSF in inflammation

  2019cites this paper
• Granulocyte macrophage colony-stimulating factor induces CCL 17 production via IRF 4 to mediate inflammation

  2019cites this paper
• TNF and granulocyte macrophage-colony stimulating factor interdependence mediates inflammation via CCL17.

  2018cites this paper
• Tofacitinib inhibits granulocyte–macrophage colony-stimulating factor-induced NLRP3 inflammasome activation in human neutrophils

  2018cites this paper
• Investigational therapies targeting the granulocyte macrophage colony-stimulating factor receptor-α in rheumatoid arthritis: focus on mavrilimumab

  2018cites this paper
• CSF-1 in Inflammatory and Arthritic Pain Development

  2018cites this paper
• CCL17 blockade as a therapy for osteoarthritis pain and disease

  2018cites this paper
• Cytokine-Induced Acute Inflammatory Monoarticular Arthritis.

  2018cites this paper
• 2 Animal Models of Hematopoietic Growth Factor Perturbations in Physiology and Pathology

  2017cites this paper
• Transcription factor NFAT5 promotes macrophage survival in rheumatoid arthritis

  2017cites this paper
• Spotlight on mavrilimumab for the treatment of rheumatoid arthritis: evidence to date

  2017cites this paper
• Selected cytokine pathways in rheumatoid arthritis

  2017cites this paper
• G-CSF Receptor Blockade Ameliorates Arthritic Pain and Disease

  2017cites this paper
• Targeting GM-CSF in inflammatory diseases

  2016cites this paper
• Granulocyte macrophage colony-stimulating factor induces CCL17 production via IRF4 to mediate inflammation.

  2016cites this paper
• GM-CSF: An immune modulatory cytokine that can suppress autoimmunity.

  2015cites this paper
• Intra-articular administration of an antibody against CSF-1 receptor reduces pain-related behaviors and inflammation in CFA-induced knee arthritis.

  2015cites this paper
• GM‐CSF and uPA are required for Porphyromonas gingivalis‐induced alveolar bone loss in a mouse periodontitis model

  2015cites this paper
• The detrimental effects of iron on the joint: a comparison between haemochromatosis and haemophilia

  2015cites this paper
• GOUT AS AN AUTOINFLAMMATORY DISEASE: FROM CELLULAR TO GENETIC MECHANISMS

  2014cites this paper
• Bone‐ and Cartilage‐Protective Effects of a Monoclonal Antibody Against Colony‐Stimulating Factor 1 Receptor in Experimental Arthritis

  2014cites this paper
• IL-1β and TNFα Promote Monocyte Viability through the Induction of GM-CSF Expression by Rheumatoid Arthritis Synovial Fibroblasts

  2014cites this paper
• GM-CSF as a therapeutic target in inflammatory diseases.

  2013cites this paper
• Inflammation Inhibits Osteoblast-Mediated Bone Formation in Rheumatoid Arthritis and Regulates the Wnt and BMP Signaling Pathways: A Dissertation

  2012cites this paper
• Mechanistic Modeling of Antigen Sink Effect for Mavrilimumab Following Intravenous Administration in Patients With Rheumatoid Arthritis

  2012cites this paper
• Granulocyte-macrophage colony-stimulating factor is a key mediator in experimental osteoarthritis pain and disease development

  2012influential citation
• Granulocyte-macrophage colony-stimulating factor is a key mediator in inflammatory and arthritic pain

  2012influential citation
• A mouse GM-CSF receptor antibody attenuates neutrophilia in mice exposed to cigarette smoke

  2011cites this paper
• Regulation of systemic and local myeloid cell subpopulations by bone marrow cell-derived granulocyte-macrophage colony-stimulating factor in experimental inflammatory arthritis.

  2011cites this paper
• Title: A Mouse GM-CSFR Antibody Attenuates Neutrophilia in Mice Exposed to Cigarette Smoke Running title: Anti-GM-CSFR inhibits subchronic lung injury

  2011cites this paper
• Differentiation of Inflammatory Dendritic Cells Is Mediated by NF-κB1–Dependent GM-CSF Production in CD4 T Cells

  2011influential citation
• GM-CSF Production in CD4 T CellsDependent - B1 k Cells Is Mediated by NF-Differentiation of Inflammatory Dendritic

  2011influential citation
• Bone Marrow-derived Human Hematopoietic Stem Cells Engraft NOD/SCID Mice and Traffic Appropriately to an Inflammatory Stimulus in the Joint

  2010cites this paper
• Mice and Traffic Appropriately to an Inflammatory Stimulus in the Joint Bone Marrow-derived Human Hematopoietic Stem Cells Engraft NOD / SCID

  2010cites this paper
• The dynamics of macrophage lineage populations in inflammatory and autoimmune diseases.

  2009cites this paper
• Tyrosine kinases as targets for the treatment of rheumatoid arthritis

  2009cites this paper
• Expression of steroidogenic enzymes in porcine polycystic ovaries.

  2009cites this paper
• Activation of invariant NKT cells confers protection against Chlamydia trachomatis-induced arthritis.

  2009cites this paper
• Combined blockade of granulocyte-macrophage colony stimulating factor and interleukin 17 pathways potently suppresses chronic destructive arthritis in a tumour necrosis factor α-independent mouse model

  2008cites this paper
• Colony-stimulating factors in inflammation and autoimmunity

  2008cites this paper
• Granulocyte-macrophage colony stimulating factor is anabolic and interleukin-1beta is catabolic for rat articular chondrocytes.

  2008cites this paper
• Inflammatory osteoclastogenesis can be induced by GM-CSF and activated under TNF immunity.

  2008cites this paper
• The role of granulocyte macrophage-colony-stimulating factor in acute intestinal inflammation

  2008cites this paper
• Development of acute inflammatory arthritis by granulocyte-macrophage colony-stimulating factor during autologous stem cell transplantation for cryoglobulinemia

  2007cites this paper
• Pro-apoptotic Bid is required for the resolution of the effector phase of inflammatory arthritis

  2007cites this paper
• Growth Factors, Cytokines, Cell Cycle Molecules p21 Is Required for the Development of Monocytes and Their Response to Serum Transfer-induced Arthritis

  2006cites this paper
• Posttranscriptional mechanisms regulating the inflammatory response.

  2006cites this paper
• Anticorps humain monoclonal se liant au gm-csf humain et site de liaison à l'antigène de cet anticorps

  2006cites this paper
• p21Cip1 is required for the development of monocytes and their response to serum transfer-induced arthritis.

  2006cites this paper
• Early cytokine profiles in the joint define pathogen clearance and severity of arthritis in Chlamydia-induced arthritis in rats.

  2006cites this paper
• Innate immunity and arthritis: neutrophil Rac and toll-like receptor 4 expression define outcomes in infection-triggered arthritis.

  2005cites this paper
• Acute CD4+ T lymphocyte-dependent interleukin-1-driven arthritis selectively requires interleukin-2 and interleukin-4, joint macrophages, granulocyte-macrophage colony-stimulating factor, interleukin-6, and leukemia inhibitory factor.

  2005cites this paper
• Functions of granulocyte-macrophage colony-stimulating factor.

  2005cites this paper
• Animal Models of Hematopoietic Growth Factor Perturbations in Physiology and Pathology

  2004cites this paper
• Colony-Stimulating Factor in Inflammation Granulocyte-Macrophage Stimulus-Dependent Requirement for

  2004cites this paper
• Molecular targets in immune-mediated diseases: focus on rheumatoid arthritis

  2004cites this paper
• Stimulus-Dependent Requirement for Granulocyte-Macrophage Colony-Stimulating Factor in Inflammation1

  2004cites this paper
• From Human Monocytes Factor Production and Angiogenic Activity M-CSF Induces Vascular Endothelial Growth

  2003cites this paper
• No association between human parvovirus B19 infection and Sjögren's syndrome.

  2003cites this paper
• Osteoclasts, pro-inflammatory cytokines, RANK-L and bone remodeling in rheumatoid arthritis.

  2003cites this paper
• Suppressor of cytokine signaling-1 regulates acute inflammatory arthritis and T cell activation.

  2003cites this paper
• Severe septicaemia in a patient with polychondritis and Sweet's syndrome after initiation of treatment with infliximab.

  2003cites this paper
• Recurrent uveitis in a patient with juvenile spondyloarthropathy associated with tumour necrosis factor alpha inhibitors.

  2003cites this paper
• Severe septicaemia in a patient with polychondritis and Sweet’s syndrome after initiation of treatment with infliximab

  2003cites this paper
• M-CSF Induces Vascular Endothelial Growth Factor Production and Angiogenic Activity From Human Monocytes 1

  2003cites this paper
• Severe septicaemia in a patient with polychondritis and Sweet’s syndrome after initiation of treatment with infliximab

  2002cites this paper
• GM-CSF in inflammation and autoimmunity.

  2002cites this paper
• Severe septicaemia in a patient with polychondritis and Sweet’s syndrome after initiation of treatment with infliximab

  2002cites this paper
• T and B Cell Recovery in Arthritis Adoptively Transferred to SCID Mice: Antigen-Specific Activation Is Required for Restoration of Autopathogenic CD4+ Th1 Cells in a Syngeneic System1

  2002cites this paper
• Severe septicaemia in a patient with polychondritis and Sweet’s syndrome after initiation of treatment with infliximab

  2002cites this paper
• Severe septicaemia in a patient with polychondritis and Sweet’s syndrome after initiation of treatment with infliximab

  2002cites this paper
• Severe septicaemia in a patient with polychondritis and Sweet’s syndrome after initiation of treatment with infliximab

  2002cites this paper
• Cytokines and cellular interactions in inflammatory synovitis.

  2001cites this paper
• Granulocyte colony-stimulating factor therapy resulting in a flare of systemic lupus erythematosus: comment on the article by Yang and Hamilton.

  2001cites this paper
• Tissue-Type Plasminogen Activator Deficiency Exacerbates Arthritis1

  2001cites this paper
• Tissue-Type Plasminogen Activator Deficiency Exacerbates Arthritis 1

  2001cites this paper
• Extended Report

  year unknowncites this paper
• Extended Report

  year unknowncites this paper
• Severe septicaemia in a patient with polychondritis and Sweet’s syndrome after initiation of treatment with infliximab

  year unknowncites this paper